Archives for the month of: July, 2010

Scientists have devised a technique to watch, in real time, the dynamic ebb and flow of brain connections in young mouse models of fragile X syndrome. The findings appeared in June in the Journal of Neuroscience.

Postmortem tissue from people with the syndrome and static images of the brains of young mouse models3 have both shown that fragile X brains look much less mature than do the brains of control animals. For example, they have abnormally long and dense dendritic spines — the slender neuronal projections that receive electrical messages from other cells and that are heavily pruned during development.

The new work shows, however, that dendrites in the fragile X brain appear more normal than those studies suggested.

“This is a big deal,” notes Anis Contractor, assistant professor of physiology at Northwestern University, who was not involved in the study. “It contradicts the dogma in the field that in all parts of the cortex [in fragile X] there’s this immature, delayed development.”

Read more at…

SFARI, July 2010.

Families affected by fragile X syndrome can let out a modest cheer this week: the largest-ever randomized trial of a drug to treat the syndrome has just cleared its second phase.

The drug, dubbed STX209, is further along than any other treatment for an autism-related disorder. If it passes the next, more rigorous testing phase, it could be in clinics within a few years.

At a meeting on Saturday of the National Fragile X Foundation, Seaside Therapeutics, a small biotech in Cambridge, Massachusetts, announced that in 15 children who had both fragile X syndrome and severe social impairments, STX209 significantly improved scores on several tests of social behaviors.

Read more at…

SFARI, July 2010.

Using a microscope, a floating foam ball, and rock-steady hands, Janelia Farm researchers have developed a way to measure the brain activity of a fruit fly while it is walking. The new technique literally creates a window into the tiny tangle of neurons in the insect’s brain, so that researchers can watch as those cells work together to let the fly move and respond to changes in its environment.

Established methods had allowed researchers to image in real time as neurons in the brains of larger species, such as rats and mice, signaled to one another during behavior. The new technique, developed in the lab of Vivek Jayaraman, a group leader at the Howard Hughes Medical Institute’s Janelia Farm Research Campus, is the first to do so in the tiny brain of Drosophila melanogaster. Vivek and his collaborators demonstrated this sophisticated system in a study published July 24, 2010 in Current Biology. In that work, the researchers report that they used the technique to learn that neurons in the fly’s optic lobes—regions of the brain that process vision—are tuned differently to the speed of external motion when the insect is walking and when it is stationary.

Read more at…

HHMI News, July 2010.

Families with autism often have a history of other psychiatric illnesses. Topping this list is obsessive-compulsive disorder, or OCD, which is characterized by repeating behaviors such as handwashing.

No one has pinpointed genes or pathways that cause the condition and, partly because it can be triggered by ordinary stressors, it’s difficult to diagnose. Its biology becomes even more baffling with the release of two new mouse models of compulsive behaviors, each implicating a different type of brain cell.

Read more at…

SFARI, July 2010.

There is a formidable arsenal of drugs available to treat HIV. For the first time in years, there is also renewed hope of a cure.

Nature, July 2010.

US drug companies are preparing for new draconian provisions for reporting on financial relationships with academia. Will efforts to increase transparency prove burdensome to researchers and the industry?

Read more at…

Nature Biotechnology, July 2010.

Compared with the trust-inducing oxytocin or the fight-or-flight power of adrenaline, vasopressin may seem rather dull. The hormone is known mostly for its ability to control blood pressure and water absorption in the kidneys.

In the past few years, though, studies have revealed vasopressin’s flashier side. It turns out that the hormone controls emotions including anxiety, fear and aggression. A new study in the Journal of Neuroscience for the first time pinpoints the brain circuits that underlie these abilities.

Inhaled vasopressin has been shown to provoke aggressive responses to faces, and to cause people to judge others’ faces as less friendly, than they would otherwise.

Read more at…

SFARI, July 2010.

The mouse brain has more than 1,300 regions for which the copy from one parent is expressed more often than the one from the other parent, according to two studies published today in Science. These so-called imprinted genes have been proposed to cause some cases of autism, but the researchers say their findings do not support that theory.

The identified regions include 824 genes, of which 604 have known human counterparts. Statistical models predicted the existence of only a few hundred imprinted genes. Scientists had identified fewer than 100, and tied them to a number of conditions ranging from embryonic growth to autism and schizophrenia.

Using sophisticated sequencing methods, the new work gives the first high-resolution picture of imprinting across the genome.

Experts applaud the studies for their thoroughness, but caution that imprinting patterns in humans might be different than in mice.

“[The new work] is a really important milestone for saying we need to do this for humans,” says Bernie Crespi, professor of evolutionary biology at Simon Fraser University in British Columbia, who was not involved in the new studies. “If we do that, we might find a good chunk of the missing heritability of any number of psychiatric conditions.”

Read more at…

SFARI, July 2010.

Brains of children with fragile X syndrome go through an abnormal trajectory of development in the first few years of life, according to the first study to track how the disease unfolds in the brain. The findings were published in May in the Proceedings of the National Academy of Sciences.

Fragile X syndrome — a genetic disease that causes mental retardation and often autism — results from the complete loss of fragile X mental retardation protein, or FMRP, which is important for many brain processes. By comparing children with the syndrome and healthy controls, the new findings present a picture of when and where FMRP is expressed during early development.

“This is beautiful work,” says April Benasich, director of the Infancy Studies Laboratory at Rutgers University, who was not involved in the study. “The ability to link individual differences in the structure of the brain to some genetic precursor is extremely powerful.”

Read more at…

SFARI, July 2010.

Follow

Get every new post delivered to your Inbox.